JP2022536932A5 - - Google Patents

Info

Publication number
JP2022536932A5
JP2022536932A5 JP2021574818A JP2021574818A JP2022536932A5 JP 2022536932 A5 JP2022536932 A5 JP 2022536932A5 JP 2021574818 A JP2021574818 A JP 2021574818A JP 2021574818 A JP2021574818 A JP 2021574818A JP 2022536932 A5 JP2022536932 A5 JP 2022536932A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
asthma
composition according
administered
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574818A
Other languages
English (en)
Japanese (ja)
Other versions
JP7607939B2 (ja
JP2022536932A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/037696 external-priority patent/WO2020257093A1/en
Publication of JP2022536932A publication Critical patent/JP2022536932A/ja
Publication of JP2022536932A5 publication Critical patent/JP2022536932A5/ja
Application granted granted Critical
Publication of JP7607939B2 publication Critical patent/JP7607939B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021574818A 2019-06-17 2020-06-15 喘息を治療するための方法 Active JP7607939B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962862434P 2019-06-17 2019-06-17
US62/862,434 2019-06-17
PCT/US2020/037696 WO2020257093A1 (en) 2019-06-17 2020-06-15 Method for treating asthma

Publications (3)

Publication Number Publication Date
JP2022536932A JP2022536932A (ja) 2022-08-22
JP2022536932A5 true JP2022536932A5 (https=) 2023-06-22
JP7607939B2 JP7607939B2 (ja) 2025-01-06

Family

ID=74040873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574818A Active JP7607939B2 (ja) 2019-06-17 2020-06-15 喘息を治療するための方法

Country Status (8)

Country Link
US (1) US20220087969A1 (https=)
EP (1) EP3983070B1 (https=)
JP (1) JP7607939B2 (https=)
CN (1) CN114007690B (https=)
AU (1) AU2020296829B2 (https=)
CA (1) CA3141407A1 (https=)
MX (1) MX2021015561A (https=)
WO (1) WO2020257093A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2651407B1 (en) * 2010-12-15 2016-12-21 Olatec Industries LLC 3-methanesulfonylpropionitrile for treating inflammation and pain
FR3046933B1 (fr) * 2016-01-25 2018-03-02 Galderma Research & Development Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires
US11597706B2 (en) * 2016-04-18 2023-03-07 Novartis Ag Compounds and compositions for treating conditions associated with NLRP activity

Similar Documents

Publication Publication Date Title
JP2015526458A5 (https=)
RU2011101151A (ru) Интраназальные композиции, содержащие деконгестант и кортикостероид
JP2014515373A5 (https=)
JP2011528355A5 (https=)
JP2023522010A5 (https=)
JP2023520323A5 (https=)
JP2009508854A (ja) 睡眠時呼吸障害の予防及び治療方法及び手段
JP2010540607A (ja) セチリジンと、非β２−アドレナリン受容体作動薬、β２−アドレナリン受容体作動薬、又は抗炎症薬とを含む組成物及びそれらの呼吸器疾患治療への使用法
JP2005508963A5 (https=)
CN100558358C (zh) 唑尼沙胺在制备用于治疗或预防阻塞性睡眠呼吸暂停的药物中的应用
JP2023523557A5 (https=)
JP2019507786A5 (https=)
JP2019516797A5 (https=)
EP4494700A3 (en) New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases
JP2022536932A5 (https=)
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
JP2006508994A5 (https=)
JP2017511307A5 (https=)
CN108014106A (zh) 卡格列净在制备用于辅助治疗特发性肺纤维化的药物中的应用
WO2015135372A1 (zh) 异佛司可林在防治慢性阻塞性肺病中的应用
JP2024543259A5 (https=)
JP2024531799A5 (https=)
JP2023539847A5 (https=)
JP2009508965A (ja) 正常な呼吸リズムを回復するための組み合わせｓ−ニトロソチオールをベースとする製薬学的製品